ResMed Inc.
RMD
$208.05
-$0.93-0.45%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.60% | 6.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.60% | 6.53% | |||
| Cost of Revenue | -0.69% | 5.79% | |||
| Gross Profit | 1.39% | 6.99% | |||
| SG&A Expenses | 1.49% | 6.37% | |||
| Depreciation & Amortization | -2.43% | -1.04% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.35% | 5.64% | |||
| Operating Income | 1.07% | 8.21% | |||
| Income Before Tax | 1.24% | 11.05% | |||
| Income Tax Expenses | 0.02% | 5.39% | |||
| Earnings from Continuing Operations | 1.56% | 12.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.56% | 12.64% | |||
| EBIT | 1.07% | 8.21% | |||
| EBITDA | 2.65% | 7.97% | |||
| EPS Basic | 1.91% | 12.90% | |||
| Normalized Basic EPS | 3.09% | 7.86% | |||
| EPS Diluted | 2.24% | 13.08% | |||
| Normalized Diluted EPS | 3.20% | 8.00% | |||
| Average Basic Shares Outstanding | -0.34% | -0.23% | |||
| Average Diluted Shares Outstanding | -0.44% | -0.36% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.02% | -0.11% | |||